Morocco medicine price database

D-RUBICIN 50 MG / 50 ML

doxorubicine

Public price

409,00 MAD

Active substance

doxorubicine

Laboratory

NOVOPHARMA

What is this medicine?

An anthracycline topoisomerase inhibitor that exerts cytotoxic effects on malignant cells by inhibiting nucleotide replication and the action of DNA and RNA polymerases, and by forming DNA-cleavable complexes with topoisomerase II.

Verified summary

doxorubicine, Poudre pour usage parentéral, 50 MG / 50 ML, Boîte unitaire

Common uses

Treatment of acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms' tumor, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma, and as a component of multi-agent adjuvant chemotherapy for women with axillary lymph node involvement following resection of primary breast cancer.

Class

anthracycline topoisomerase inhibitor

Laboratory

NOVOPHARMA

Hospital price

272,00 MAD

Strength

50 MG / 50 ML

Form

Poudre pour usage parentéral

Presentation

Boîte unitaire

ATC code

L01DB01

Type

Générique

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-02: 409,00 MAD

Available presentations and strengths

Medicines with the same active substance